Myelodysplastic Syndrome (MDS) Drugs Market 2020 size, share, growth, trends to 2023

Myelodysplastic Syndrome (MDS) Drugs Market Research Report Forecast to 2023 Global Industry Survey, Growth, Competitive Landscape and Forecasts to 2023

CREATED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

Myelodysplastic Syndrome (MDS) Drugs MarketResearch Report - Forecast to 2023 Research Across Sectors to Give Impetus to Global Myelodysplastic Syndrome (MDS) Drugs Market 2023 • The Global Myelodysplastic Syndrome (MDS) Drugs Market Size is estimated to reach a significant value by showcasing a CAGR of 10.1% during the forecast period (2018-2023). It stood at USD 1,581.59 million in 2018. Rise in the number of clinical trials for testing the effects of new drugs in combination with chemotherapy can drive the market growth. Approval of decitabine, a product of Lupin Ltd, by the U.S. FDA is an indicator of the acceptance of new drugs by the market.

• The rising numbers of the geriatric populace, regulatory approvals, and advocation of clinical trials pertaining to MDS are other major drivers of the global myelodysplastic syndrome drugs market. Improvement of healthcare services by cancer centers and development of novel therapeutics can fuel the market growth successfully till 2023.

• But adverse effects of the drugs and risk of infections during blood transfusions can impede the market growth.

2

www.marketresearchfuture.com

Myelodysplastic Syndrome (MDS) Drugs Market Research Report - Forecast to 2023 Segmentation: • The Global Myelodysplastic Syndrome Drugs Market is segmented by type, type of syndrome, route of administration, and end-user.

• By type, it is segmented into immunomodulatory drugs, chemotherapy, and others. The chemotherapy segment is sub-segmented into hypomethylating drugs and conventional drugs. On the other hand, immunomodulatory drugs are further divided into thalidomide and lenalidomide.

• By type of syndrome, it is segmented into refractory cytopenia with multilineage dysplasia, refractory anemia with ringed sideroblasts, refractory cytopenia with excess blasts, refractory cytopenia, and others.

• By route of administration, it is segmented into parenteral, oral, and others.

• By end-user, it is segmented into ambulatory surgical centers, hospitals, clinics, and others. The hospitals segment is expected to contribute the maximum to the global market net earnings owing to the capability of doctors at hospitals for dealing with a large number of MDS patients.

3

www.marketresearchfuture.com

Myelodysplastic Syndrome (MDS) Drugs Market Research Report - Forecast to 2023 Application & Major Players in this Research: Myelodysplastic Syndrome (MDS) Drugs Market Prominent Players: • Sandoz, Otsuka America Pharmaceutical Inc., Celgene Europe Limited, Lupin Ltd Corporation, Shilpa Medicare Limited, Celgene Corporation, Johnson & Johnson, Reddy's Laboratories, Inc., Sun Pharmaceutical Industries Inc., and BluePoint Laboratories are prominent names in the global myelodysplastic syndrome drugs market.

Industry News • Onconova Therapeutics Inc has decided to collaborate with Mission Bio for using the latter’s platform for providing breakthrough treatments for MDS. The company plans to use it to study the effects of its targeted therapy, Rigosertib on single-cell DNA analysis.

Get Discount @ https://www.marketresearchfuture.com/check-discount/8134

4

www.marketresearchfuture.com

Myelodysplastic Syndrome (MDS) Drugs Market Research Report - Forecast to 2023 About Us: Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), ContinuousFeed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright Š 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future.

5

www.marketresearchfuture.com

THANK YOU

MARKET RESEARCH FUTURE

salesteam@marketresearchfuture.com Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

6

www.marketresearchfuture.com